Product Information
PHENYLEPHRINE 2.5% EYE DROP is a generic product labeled by Leading Pharma, LLC, priced at $9.2924 per ML under NDC 69315032308. Its NADAC has been published 100 times since Nov 6, 2024.
FDA first approved this application on May 23, 2024. Its Orange Book therapeutic-equivalence code is AT.
Strength
25 mg/mL
Manufacturer
Leading Pharma, LLCNDC
69315032308
Classification
Generic
Dosage Form
SOLUTION
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
PHENYLEPHRINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA215183FDA Approved
5/23/2024
TE Code
AT
On Market Since
9/5/2024
Pharmacological Classes
Price Statistics
The NADAC for PHENYLEPHRINE 2.5% EYE DROP has been published 100 times since Nov 6, 2024, and over the history we have for it it has declined 32.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.2924 per ML |
|---|---|
| All-time high | $13.7575 (Nov 13, 2024) |
| All-time low | $8.5534 (Feb 18, 2026) |
| 52-week high | $12.2873 |
| 52-week low | $8.5534 |
| Median price | $11.8103 |
| Average price | $11.1621 |
| Largest weekly change | -12.0% (Nov 19, 2025) |
| Weeks tracked | 100 |
| Tracking since | Nov 6, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the PHENYLEPHRINE HYDROCHLORIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Leading Pharma, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
PHENYLEPHRINE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
alpha-1 Adrenergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PHENYLEPHRINE 2.5% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for PHENYLEPHRINE 2.5% EYE DROP, manufactured by Leading Pharma, LLC, is $9.2924 per ML (NDC 69315032308), effective Sep 30, 2026.
How has the price of PHENYLEPHRINE 2.5% EYE DROP changed over time?
Over the history we have for it, the NADAC for PHENYLEPHRINE 2.5% EYE DROP has declined 32.5%. It has been tracked across 100 weekly CMS publications since Nov 6, 2024.
What are the highest and lowest recorded NADAC prices for PHENYLEPHRINE 2.5% EYE DROP?
Since Nov 6, 2024, the NADAC for PHENYLEPHRINE 2.5% EYE DROP has ranged from a low of $8.5534 (Feb 18, 2026) to a high of $13.7575 (Nov 13, 2024), with a median of $11.8103 per ML.
Are there cheaper alternatives to PHENYLEPHRINE 2.5% EYE DROP?
No other NADAC-published product currently shares the active ingredient and strength of PHENYLEPHRINE 2.5% EYE DROP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures PHENYLEPHRINE 2.5% EYE DROP?
PHENYLEPHRINE 2.5% EYE DROP (NDC 69315032308) is labeled by Leading Pharma, LLC, and CMS classifies it as a generic product.